-
In a must-watch video, Rachel King, co-founder and CEO of
#GlycoMimetics, urges President Trump to reject foreign price controls and ensure the U.S. continues to lead in innovation. https://buff.ly/2Ufoau4 pic.twitter.com/IqYwEZgdy3
-
Our article on original dithioacetal-α,α-diglycosides is now online
@Molecules_MDPI for the special issue on#glycomimetics http://mdpi.com/282316 pic.twitter.com/nHIg64aNjT
-
The impact
#HR3 would have on the emerging biotech community would be devastating. Rachel King, co-founder and CEO of#GlycoMimetics, explains why in must-watch new video. https://bit.ly/2sltekA -
Interesting class of new
#glycomimetics, curious how they will be recognized by other lectins. https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00356 … -
Rachel King of
#glycomimetics reinforced region ranked #1 in human capital#biotechforum16 -
BCNI trials team prepping pt research samples 4 translational components of
#GlycoMimetics#MultipleMyeloma#clinicaltrial#benchtobedsidepic.twitter.com/dFugfCZEpR
-
Thank you
@RepDavidTrone for taking time to visit#GlycoMimetics and see first-hand the biotech innovation happening in Maryland. We look forward to working together to put patients first.@MDTechCouncilpic.twitter.com/iZugf2E15Q
-
$GLYC#GlycoMimetics is a loss making on an annual basis, but Biotech investors are happy to wait
https://simplywall.st/NasdaqGM:GLYC/glycomimetics/?utm_medium=twitter&anchor=past-future-earnings#past-future-earnings …pic.twitter.com/uCtc7lD6ko
-
Rachel King of
#GlycoMimetics and Gail Folena-Wasserman of @MedImmune on critical need for diversity in STEM#IWSTEMpic.twitter.com/kjXSNLgkZp
-
$GLYC#Glycomimetics Catalyst Stifel's Biotech Catalyst Stock to Buy With 60% to 100% Upside Potential http://bit.ly/11jI4oD -
TWENTY ONE!! @@altimmune
@emergentbiosolu@Cerecor#glycomimetics@MacroGenics @MedImmune@REGENXBIO@Intrexon@Neuralstem_Inc@NovavaxInc@OpGen@orogenes@SYNBiologics@supernus@maxcyte@MDBiz@BioHealthCR@think_moco@GrowGburg@BioHealthInnovhttps://twitter.com/TechnicallyBMR/status/1041869836895350788 …
-
#GlycoMimetics$GLYC to Receive European Patent for#GMI1271 http://www.1stoncology.com/blog/glycomimetics-to-receive-european-patent-for-gmi-1271 … -
Where Should
#Biotech Companies#Recruit#Scientists For The Future, And How Should#Universities Prepare#Students To Be The Biotech Workforce For The Future? https://buff.ly/2NVAeuG#GlycoMimetics' CEO Rachel King shares her wisdom@IAmBiotech@LifeSciLeader1pic.twitter.com/mY2AEYj1V6
-
#GlycoMimetics CEO King speaks during keynote at#BIO2015. Thanks for your leadership, Madame (Outgoing) Chair!pic.twitter.com/3gCD01IFPA
-
Maryland Life Sciences Advisory Board chaired by
#GlycoMimetics CEO Rachel King mtg this am. http://www.bio.maryland.gov/aboutus/pages/lsab-members.aspx …pic.twitter.com/OY2ZEJPfAh
-
Join the upcoming Special Issue
#glycomimetics@Molecules_MDPI (@compaingroup guest editor, MS deadline 30/01/2018) http://www.mdpi.com/journal/molecules/special_issues/glycomimetics#editors …pic.twitter.com/m7vw88RRAy
-
In a powerful new video, Rachel King, co-founder and CEO of
#GlycoMimetics, urges congressional leaders to vote no on#HR3 and explains why@SpeakerPelosi’s drug pricing plan would be devastating for patients and emerging biotech companies.https://bit.ly/2sltekA -
#GlycoMimetics King: Congress should also focus on those abuses perpetrated AGAINST#patent holders. http://1.usa.gov/1MN9vKd#PatentsMatter -
$GLYC to receive $9M upfront + up to $180M milestone payments from Apollomics for Uproleselan and GMI-1687 license deal in Greater China#GlycoMimetics#Apollomics http://crweworld.com/symbol/GLYC
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.